Log In
BCIQ
Print this Print this
 

IV CR845

  Manage Alerts
Collapse Summary General Information
Company Cara Therapeutics Inc.
DescriptionLong-acting peripheral kappa opioid receptor (KOR; OPRK1) agonist
Molecular Target Kappa opioid receptor (KOR) (OPRK1)
Mechanism of ActionKappa opioid receptor agonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/06/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today